Kallistatin leads to cognition impairment via downregulating glutamine synthetase

Kallistatin leads to cognition impairment via downregulating glutamine synthetase

In many neurodegenerative disorders, such as Alzheimer's disease (AD), glutamate-mediated neuronal excitotoxicity is considered the basis for cognitive impairment. The mRNA and protein expression of SERPINA4(Kallistatin) are higher in patients with AD. However, whether Kallistatin plays a regul...

Full description

Bibliographic Details
Main Authors: Yanlan Long, Zhen Zhao, Wanting Xie, Jinhui Shi, Fengyu Yang, Dan Zhu, Ping Jiang, Qilong Tang, Zhou Ti, Bin Jiang, Xia Yang, Guoquan Gao, Weiwei Qi
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Pharmacological Research
Subjects:
Cognition impairment
Kallistatin
Glutamine synthetase
Proteasome-mediated degradation
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661824000896

Internet

http://www.sciencedirect.com/science/article/pii/S1043661824000896

Similar Items